回耳鼻喉部首頁 /長庚醫療財團法人全球資訊網/ 林口長庚紀念醫院
未命名 1
未命名 1

醫療團隊

未命名 1


頭頸外科 回耳鼻喉部首頁 > 醫療團隊 > 頭頸外科
Head and Neck Surgery

廖俊達醫師

現職:
1. 林口長庚醫院 教授
2. 林口長庚醫院耳鼻喉部 副科部主任
3. 林口長庚醫院癌症中心頭頸癌團隊 負責人
4. 國家衛生研究院口腔癌臨床指引編撰小組委員
學歷:

台北醫學院醫學士1979 / 09 ~1986 /06


經歷:

長庚林口總院耳鼻喉部總醫師

長庚林口總院耳鼻喉部主治醫師

美國德州休士頓安德生癌症中心臨床研究員

主治專長:

專長
1. 頭頸部腫瘤手術
2. 頭頸部腫瘤分子生物學
3. 頭頸部腫瘤統計學

主要研究領域
1.口腔癌的開刀準則及影響預後的危險因子分析。
2.口腔癌分子影像。

論文著作

1. Liao CT, Fan KH, Lin CY, Wang HM, Huang SF, Chen IH, Kang CJ, Ng SH, Hsueh C, Lee LY, Lin CH, Yen TC. Impact of a second FDG-PET before adjuvant therapy for the early detection of residual/relapsing tumours in high-risk patients with oral cavity cancer and pathological extracapsular spread. Eur J Nucl Med Mol I. . 2012 Jun;39(6):944-55. (IF = 5.036)

2. Liao CT, Hsueh C, Lee LY, Lin CY, Fan KH, Wang HM, Huang SF, Chen IH, Kang CJ, Ng SH, Tsao CK, Huang YC, Yen TC. Neck dissection field and lymph nodes density predict prognosis in patients with oral cavity cancer and pathological node metastases treated by adjuvant therapy Oral Oncol. 2011 Nov 19. [Epub ahead of print] (IF = 2.871)
3. Liao CT, Lin CY, Fan KH, Wang HM, Ng SH, Lee LY, Hsueh C, Chen IH, Huang SF, Kang CJ, Yen TC. Identification of a high risk group among patients with oral cavity squamous cell carcinoma and pT1-2N0 disease. Int J Radiat Oncol Biol Phys. 2012 Jan 82:284-90. (IF = 4.503)
4. Kang CJ, Lin CY, Wang HM, Fan KH, Ng SH, Lee LY, Chen IH, Huang SF, Liao CT*c, Yen TC. The number of pathologically-positive lymph nodes and pathological tumor depth predict prognosis in patients with poorly-differentiated squamous cell carcinoma of the oral cavity. Int J Radiat Oncol Biol Phys. 2011 Nov 81:e223-30. (IF = 4.503)
5. Liao CT&*c, Lee LY, Huang SF, Chen IH, Kang CJ, Lin CY, Fan KH, Wang HM, Ng SH, Yen TC. Outcome analysis of patients with oral cavity cancer and extracapsular spread in neck lymph nodes. Int J Radiat Oncol Biol Phys. 2011 Nov;81:930-7. (IF = 4.503)
6. Kang CJ, Liao CT*F, Hsueh C, Lee LY, Lin CY, Fan KH, Wang HM, Huang SF, Chen IH, Ng SH, Tsao CK, Huang YC, Yen TC. Outcome analysis of patients with well-differentiated oral cavity squamous cell carcinoma. Oral Oncol. 2011 Nov;47:1085-91. (IF = 2.871)
7. Cheng NM, Yeh TW, Ho KC, Ng SH, Hsueh C, Yen TC, Liao CT*c. False positive F-18 fluorodeoxyglucose PET/CT in neck and mediastinum lymph nodes due to anthracosis in a buccal cancer patient. Clin Nucl Med. 2011 Oct;36:963-4. (IF = 3.766)
8. Liao CT, Lin CY, Fan KH , Huang SF, Chen IH, Kang CJ, Wang HM, Ng SH, Hsueh C, Lee LY, Lin CH, Yen TC. Identification of a high-risk subgroup of patients with resected pT3 oral cavity cancer in need for postoperative adjuvant therapy. Ann Surg Oncol. 2011 Sep;18:2569-78. (IF = 4.182)
9. Peng CH, Liao CT*F, Peng SC, Chen YJ, Cheng AJ, Juang JL, Tsai CY, Chen TC,  Chuang YJ, Tang CY, Hsieh WP, Yen TC. A novel molecular signature identified by systems genetics approach predicts prognosis in oral squamous cell carcinoma. PLoS One. 2011;6:e23452. (IF = 4.411)
10. Liu FY, Liao CT*c, Yen TC. Synchronous malignancies in patients with squamous cell carcinomas of the oral cavity. Eur J Nucl Med Mol I. 2011 June;38:1020-8. (IF = 5.036)
11. Abd El-Hafez YG, Chen CC, Ng SH, Lin CY, Wang HM, Chan SC, Chen IH, Fu Huan SF, Kang CJ, Lee LY, Lin CH, Liao CT*c, Yen TC. Comparison of PET/CT and MRI for the detection of bone marrow invasion in patients with squamous cell carcinoma of the oral cavity. Oral Oncol. 2011 Apr;47:288-95. (IF = 2.871)
12. Liao CT, Wang HM, Huang SF, Chen IH, Kang CJ, Lin CY, Fan KH , Ng SH, Hsueh C, Lee LY, Lin CH, Yen TC. PET and PET/CT of the neck lymph nodes improves risk prediction in patients with squamous cell carcinoma of the oral cavity. J Nucl Med. 2011 Feb;52:180-7. (IF = 7.022)
13. Liao CT&*c, Huang SF, Chen IH, Kang CJ, Lin CY, Fan KH, Wang HM, Ng SH, Hsueh C, Lee LY, Lin CH, Yen TC. Tongue and buccal mucosa carcinoma: Is there a difference in outcome? Ann Surg Oncol. 2010 Nov;17:2984-91. (IF = 4.182)
14. Liao CT, Wang HM, Chang JT, Lin CY, Huang SF, Chen IH, Ng SH, Hsueh C, Lee LY, Lin CH, Cheng AJ, Yen TC. The influence of pathological nodal status and SUVmax of the primary tumor and regional lymph nodes on treatment plans in patients with advanced oral cavity squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2010 Jun;77:421-9. (IF = 4.503)
15. Liao CT&*c, Huang SF, Chen IH, Kang CJ, Lin CY, Fan KH, Wang HM, Ng SH, Hsueh C, Lee LY, Tsao CK, Yen TC. Outcome analysis of patients with pN2 oral cavity cancer. Ann Surg Oncol. 2010 Apr;17:1118-26. (IF = 4.182)
16. Liao CT, Chang JT, Wang HM, Ng SH, Huang SF, Chen IH, Hsueh C, Lee LY, Lin CH, Cheng AJ, Yen TC. Preoperative [18F] fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes may aid in selecting patients with oral cavity squamous cell carcinoma for salvage therapy after relapse. Eur J Nucl Med Mol I. 2009 Nov;36:1783-93. (IF = 5.036)
17. Liao CT, Chang JT, Wang HM, Ng SH, Hsueh C, Lee LY, Lin CH, Chen IH, Huang SF, Cheng AJ, Yen TC. Preoperative 18F-FDG PET standardized uptake value of neck lymph nodes predicts neck control and survival rates in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes. Int J Radiat Oncol Biol Phys. 2009 Jul;74:1054-61. (IF = 4.503)
18. Liao CT, Chang JT, Wang HM, Ng SH, Hsueh C, Lee LY, Lin CH, Chen IH, Huang SF, Cheng AJ, See LC, Yen TC. Pretreatment primary tumor SUVmax measured by FDG-PET and pathological tumor depth predict poor outcomes in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes. Int J Radiat Oncol Biol Phys. 2009 Mar;73:764-71. (IF = 4.503)
19. Liao CT, Huang SF, Chen IH, Chang JT, Wang HM, Ng SH, Hsueh C, Lee LY, Lin CH,  Cheng AJ, Yen TC. Risk stratification of patients with oral cavity squamous cell carcinoma and contralateral neck recurrence following radical surgery. Ann Surg Oncol. 2009 Jan;16:159-70. (IF = 4.182)
20. Liao CT, Huang SF, Chen IH, Chang JT, Wang HM, Ng SH, Hsueh C, Lee LY, Lin CH, Cheng AJ, Yen TC. When does skin excision allow the achievement of an adequate local control rate in patients with squamous cell carcinoma involving the buccal mucosa. Ann Surg Oncol. 2008 Aug;15;2187-94. (IF = 4.182)
21. Liao CT, Chang JT, Wang HM, Ng SH, Hsueh C, Lee LY, Lin CH, Chen IH, Huang SF, Cheng AJ, See LC, Yen TC. Does adjuvant radiation therapy improve outcome in pT1-3N0 oral cavity cancer with tumor-free margins and peripheral invasion? Int J Radiat Oncol Biol Phys. 2008 Jun;71:371-6. (IF = 4.503)
22. Liao CT, Chang JT, Wang HM, Ng SH, Hsueh C, Lee LY, Lin CH, Chen IH, Huang SF, Cheng AJ, Yen TC. Analysis of risk factors predictive of local tumor control in oral cavity cancer. Ann Surg Oncol. 2008 Mar;15:915-22. (IF = 4.182)
23. Liao CT, Chang JT, Wang HM, Ng SH, Hsueh C, Lee LY, Lin CH, Chen IH, Huang SF, Cheng AJ, Yen TC. Salvage therapy in relapsed squamous cell carcinoma of the oral cavity: How and when? Cancer. 2008 Jan;112:94-103. (IF = 5.131)
24. Liao CT, Wang HM, Chang JT, Ng SH, Hsueh C, Lee LY, Lin CH, Chen IH, Huang SF, Yen TC. Analysis of risk factors for distant metastases in squamous cell carcinoma of the oral cavity. Cancer. 2007 Oct;110:1501-8. (IF = 5.131)
25. Liao CT, Kang CJ, Chang JT, Wang HM, Ng SH, Hsueh C, Lee LY, Lin CH, Cheng AJ, Chen IH, Huang SF, Yen TC. Survival of second and multiple primary tumors in patients with oral cavity squamous cell carcinoma in the betel quid chewing area. Oral Oncol. 2007 Sep;43:811-9. (IF = 2.871)
26. Liao CT, Chang JT, Wang HM, Ng SH, Hsueh C, Lee LY, Lin CH, Chen IH, Huang SF, Cheng AJ, Yen TC. Survival in squamous cell carcinoma of the oral cavity: differences between pT4N0 and other stage IVA categories. Cancer. 2007 Aug;110:564-71. (IF = 5.131)
27. Liao CT, Ng SH, Chang JT, Wang HM, Hsueh C, Lee LY, Tsao CK, Chen WH, Chen IH, Kang CJ, Huang SF, Yen TC. T4b oral cavity cancer below the mandibular notch is resectable with a favorable outcome. Oral Oncol. 2007 Jul;43:570-9. (IF = 2.871)
28. Ng SH, Yen TC, Chang JT, Chan SC, Ko SF, Wang HM, Lee LY, Kang CJ, Wong AM, Liao CT*c. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck. J Clin Oncol. 2006 Sep;24:4371-6. (IF = 18.97)
29. Liao CT, Wang HM, Ng SH, Yen TC, Lee LY, Hsueh C, Wei FC, Chen IH, Kang CJ, Huang SF, Chang JT. Good tumor control and survivals of squamous cell carcinoma of buccal mucosa treated with radical surgery with or without neck dissection in Taiwan. Oral Oncol. 2006 Sep;42:800-9. (IF = 2.871)
30. Liao CT, Wang HM, Hsieh LL, Chang JT, Ng SH, Hsueh C, Lee LY, Lin CH, Chen IH, Kang CJ, Huang SF, Yen TC. Higher distant failure in young age tongue cancer patients. Oral Oncol. 2006 Aug;42:718-25. (IF = 2.871)
31. Liao CT, Chang JT, Wang HM, Ng SH, Hsueh C, Lee LY, Lin CH, Chen IH, Kang CJ, Huang SF, Yen TC. Surgical outcome of T4a and resected T4b oral cavity cancer. Cancer. 2006 Jul;107:337-44. (IF = 5.131)
32. Chang JT, Lin CY, Chen TM, Kang CJ, Ng SH, Chen IH, Wang HM, Cheng AJ, Liao CT*c. Nasopharyngeal carcinoma with cranial nerve palsy: The importance of MRI for radiotherapy. Int J Radiat Oncol Biol Phys. 2005 Dec;63:1354-60. (IF = 4.503)
33. Liao CT, Kuo TT. Images in pathology. Melanotic oncocytic metaplasia of the nasopharynx. Int J Surg Pathol. 2005 Jul;13:279. (IF = 1.134)
34. Yen TC, Chang JT, Ng SH, Chang YC, Chan SC, Wang HM, See LC, Chen TM, Kang CJ, Wu YF, Lin KJ, Liao CT*c. Staging of untreated squamous cell carcinoma of buccal mucosa with 18F-FDG PET: Comparison with head and neck CT/MRI and histopathology. J Nucl Med. 2005 May;46:775-81. (IF = 7.022)
35. Liao CT, Tung-Chieh Chang J, Wang HM, Chen IH, Lin CY, Chen TM, Hsieh LL, Cheng AJ. Telomerase as an independent prognostic factor in head and neck squamous cell carcinoma. Head Neck. 2004 Jun;26:504-12. (IF = 2.182)
36. Liao CT, Chen IH, Chang JT, Wang HM, Hsieh LL, Cheng AJ.. Lack of correlation of betel nut chewing, tobacco smoking, and alcohol consumption with telomerase activity and the severity of oral cancer. Chang Gung Med J. 2003 Sep 26:637-45.
37. Liao CT, Tsai MH, Huang TS. Mandibular swing for parapharyngeal tumor: report of two cases. J Otolaryngol Society, ROC. 1992;27:264-9. 
38. Pai PC, Chuang CC, Tseng CK, Tsang NM, Chang KP, Yen TC, Liao CT, Hong JH,
Chang JT. Impact of pretreatment body mass index on patients with head-and-neck
cancer treated with radiation. Int J Radiat Oncol Biol Phys. 2012 Feb 17. [Epub
ahead of print]
39. Hsu CL, Chang KP, Lin CY, Chang HK, Wang CH, Lin TL, Liao CT, Tsang NM, Lee LY, Chan SC, Ng SH, Li HP, Chang YS, Wang HM. Plasma epstein-barr virus DNA concentration and clearance rate as novel prognostic factors for metastatic nasopharyngeal carcinoma. Head Neck. 2011 Nov 15. [Epub ahead of print] (IF = 2.182)
40. Huang SF, Cheng SD, Chien HT, Liao CT, Chen IH, Wang HM, Chuang WY, Wang CY, Hsieh LL. Relationship between epidermal growth factor receptor gene copy number and protein expression in oral cavity squamous cell carcinoma. Oral Oncol. 2012;48:67-72. (IF = 2.871)
41. Huang SF, Cheng SD, Chuang WY, Chen IH, Liao CT, Wang HM, Hsieh LL. Cyclin D1 
overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell 
carcinoma. World J Surg Oncol. 2012 Feb 16;10:40. (IF = 1.116)
42. Chang KP, Tsang NM, Liao CT, Hsu CL, Chung MJ, Lo CW, Chan SC, Ng SH, Wang HM, Yen TC. Prognostic significance of 18F-FDG PET parameters and plasma Epstein-Barr virus DNA load in patients with nasopharyngeal carcinoma. J Nucl Med. 2012 Jan;53:21-8. (IF = 7.022)
43. Hsieh CH, Chang JW, Hsieh JJ, Hsu T, Huang SF, Liao CT, Wang HM. Epidermal growth factor receptor mutations in patients with oral cavity cancer in a betel nut chewing-prevalent area. Head Neck. 2011 Dec;33:1758-64. (IF = 2.182)
44. Chang KP, Yu JS, Chien KY, Lee CW, Liang Y, Liao CT, Yen TC, Lee LY, Huang LL, Liu SC, Chang YS, Chi LM. Identification of PRDX4 and P4HA2 as metastasis-associated proteins in oral cavity squamous cell carcinoma by comparative tissue proteomics of microdissected specimens using iTRAQ technology. J Proteome Res. 2011 Nov;10:4935-47 (IF = 5.46)
45. Chan SC, Chang JT, Lin CY, Ng SH, Wang HM, Liao CT, Chang CJ, Lin SY, Yen TC. Clinical utility of 18F-FDG PET parameters in patients with advanced nasopharyngeal carcinoma: predictive role for different survival endpoints and impact on prognostic stratification. Nucl Med Commun. 2011 Nov;32:989-96. (IF = 1.367)
46. Lin CY, Lin TY, Wang HM, Huang SF, Fan KH, Liao CT, Chen IH, Lee LY, Li YL,
Chen YJ, Cheng AJ, Chang JT. GP96 is over-expressed in oral cavity cancer and is 
a poor prognostic indicator for patients receiving radiotherapy. Radiat Oncol.
2011 Oct 12;6:136. (IF = 2.409)
47. Lin CH, Wallace C, Liao CT. Functioning free gracilis myocutaneous flap transfer provides a reliable single-stage facial reconstruction and reanimation following tumor ablation. Plast Reconstr Surg. 2011 Sep;128:687-696. (IF = 2.635)
48. Chan SC, Wang HM, Yen TC, Lin CY, Chin SC, Liao CT, Wai YY, Wang JJ, Ng SH. (18)F-FDG PET/CT and 3.0-T whole-body MRI for the detection of distant metastases and second primary tumours in patients with untreated oropharyngeal/hypopharyngeal carcinoma: a comparative study. Eur J Nucl Med Mol I. 2011;Sep:38:1607-19. (IF = 5.036)
49. Chiu CC, Lin CY, Lee LY, Chen YJ, Lu YC, Wang HM, Liao CT, Chang JT, Cheng AJ. Molecular chaperones as a common set of proteins that regulate the invasion phenotype of head and neck cancer. Clin Cancer Res. 2011 Jul;17:4629-41. (IF = 7.338)
50. Ng SH, Chan SC, Yen TC, Liao CT, Lin CY, Tung-Chieh Chang J, Ko SF, Wang HM, Chang KP, Fan KH. PET/CT and 3-T whole-body MRI in the detection of malignancy in treated oropharyngeal and hypopharyngeal carcinoma. Eur J Nucl Med Mol I. 2011 June;38:996-1008. (IF = 5.036)
51. Chang KP, Chang YT, Liao CT, Yen TC, Chen IH, Chang YL, Liu YL, Chang YS, Yu JS, Wu CC. Prognostic cytokine markers in peripheral blood for oral cavity squamous cell carcinoma identified by multiplexed immunobead-based profiling. Clin Chim Acta. 2011 May;412:980-7. (IF = 2.388)
52. Chien HT, Liao CT, Huang SF, Chen IH, Liu TY, Jou YS, Wang HM, Hsieh LL. Clinical significance of genome-wide minimally deleted regions in oral squamous cell carcinomas. Genes Chromosomes Cancer. 2011 May;50:358-69. (IF = 3.99)
53. Chen SC, Lai YH, Cheng SY, Liao CT, Chang JT. Psychometric testing of the Chinese-version cancer needs questionnaire short form head and neck cancer-specific version in oral cavity cancer patients. Support Care Cancer. 2011 May;19:647-56. (IF = 2.058)
54. Chen HH, Chen IH, Liao CT, Wei FC, Lee LY, Huang SF. Preoperative circulating C-reactive protein levels predict pathological aggressiveness in oral squamous cell carcinoma. Clin Otolaryngol. 2011 Apr;36:147-53. (IF = 1.561)
55. Kao HK, Guo LF, Cheng MH, Chen IH, Liao CT, Fang KH, Yu JS, Chang KP. Predicting postoperative morbidity and mortality by model for end stage liver disease score for patients with head and neck cancer and liver cirrhosis. Head Neck. 2011 Apr;33:529-34. (IF = 2.182)
56. Chen SC, Liao CT, Chang JT. Orofacial pain and predictors in oral squamous cell carcinoma patients receiving treatment. Oral Oncol. 2011 Feb;47:131-5. (IF = 2.871)
57. Chang KP, Kao HK, Yen TC, Chang YL, Liang Y, Liu SC, Lee LY, Chang YL, Kang CJ, Chen IH, Liao CT, Yu JS. Overexpression of macrophage inflammatory protein-3α in oral cavity squamous cell carcinoma is associated with nodal metastasis. Oral Oncol. 2011 Feb;47:108-13. (IF = 2.871)
58. Chen YJ, Liao CT*F, Chen PL, Lee LY, Li YC, Chen IH, Wang HM, Chang JT, Chen LJ, Yen TC, Tang CY, Cheng AJ. Downregulation of Ches 1 and other novel genes in oral cancer cells chronically exposed to areca nut extract. Head Neck. 2011 Feb;33:257-66. (IF = 2.182)
59. Yen TC, Liao CT. Statistical issues involved in "Risk stratification of patients with oral cavity squamous cell carcinoma and contralateral neck recurrence following radical surgery". Ann Surg Oncol. 2011 Jan;18:295-6. (IF = 4.182)
60. Lin WN, Huang HC, Wu CC, Liao CT, Chen IH, Kan CJ, Huang SF. Analysis of acinic cell carcinoma of the parotid gland - 15 years experience. Acta Otolaryngol. 2010 Dec;130:1406-10. (IF = 1.2)
61. Lin CY, Wang HM, Kang CJ, Lee LY, Huang SF, Fang KH, Chen EY, Chen IH, Liao CT, Chang JT. Primary tumor site as a predictor of treatment outcome for definite radiotherapy of advanced-stage oral cavity cancer. Int J Radiat Oncol Biol Phys. 2010 Nov;78:1011-9. (IF = 4.503)
62. Chang MF, Wang HM, Kang CJ, Huang SF, Lin CY, Fang KH, Chen EY, Chen IH, Liao CT, Chang JT. Treatment results for hypopharyngeal cancer by different treatment strategies and its secondary primary - an experience in Taiwan. Radiat Oncol. 2010 Oct 7;5:91 (IF = 2.409)
63. Chan SC, Chu CW, Liao CT, Lui KW, Ko SF, Ng SH. Complications of fluoroscopically guided percutaneous gastrostomy with large-bore balloon-retained catheter in patients with head and neck tumors. J Formos Med Assoc. 2010 Aug;109:603-8. (IF = 1.125)
64. Lin TY, Chang JT, Wang HM, Chan SH, Chiu CC, Lin CY, Fan KH, Liao CT, Chen IH, Liu TZ, Li HF, Cheng AJ. Proteomics of the radioresistant phenotype in head-and-neck cancer: Gp96 as a novel prediction marker and sensitizing target for radiotherapy. Int J Radiat Oncol Biol Phys. 2010 Sep;78:246-56. (IF = 4.503)
65. Ng SH, Chan SC, Yen TC, Liao CT, Chang JT, Ko SF, Wang HM, Lin CY, Chang KP, Lin YC. Comprehensive imaging of residual/ recurrent nasopharyngeal carcinoma using whole-body MRI at 3 T compared with FDG-PET-CT. Eur Radiol. 2010 Sep;20:2229-40. (IF = 3.594)
66. Lin CY, Chen WH, Liao CT, Chen IH, Chiu CC, Wang HM, Yen TC, Lee LY, Chang JT, Cheng AJ. Positive association of glucose-regulated protein 78 during oral cancer progression and the prognostic value in oral precancerous lesions. Head Neck. 2010 Aug;32:1028-39. (IF = 2.182)
67. Fan KH, Wang HM, Kang CJ, Lee LY, Huang SF, Lin CY, Chen EY, Chen IH, Liao CT, Chang JT. Treatment results of postoperative radiotherapy on squamous cell carcinoma of the oral cavity: coexistence of multiple minor risk factors results in higher recurrence rates. Int J Radiat Oncol Biol Phys. 2010 Jul;77:1024-9. (IF = 4.503)
68. Chen SC, Yu WP, Chu TL, Hung HC, Tsai MC, Liao CT. Prevalence and correlates of supportive care needs in oral cancer patients with and without anxiety during the diagnostic period. Cancer Nurs. 2010 Jul-Aug;33:280-9. (IF = 2.065) 
69. Chen SC, Lai YH, Liao CT, Lin CC, Chang JT. Changes of symptoms and depression in oral cavity cancer patients receiving radiation therapy. Oral Oncol. 2010 Jul;46:509-13.  (IF = 2.871)
70. Hsueh C, Chang YS, Tseng NM, Liao CT, Hsueh S, Chang JH, Wu IC, Chang KP. Expression pattern and prognostic significance of claudins 1, 4, and 7 in nasopharyngeal carcinoma. Hum Pathol. 2010 Jul;41:944-50. (IF = 2.998)
71. Liao HS, Hsueh C, Chen SC, Chen IH, Liao CT, Huang SF. Solitary nasal cavity metastasis of breast cancer. Breast J. 2010 May-Jun;16:321-2. (IF = 1.425)
72. Chen HH, Lee LY, Chin SC, Chen IH, Liao CT, Huang SF. Carcinoma ex pleomorphic adenoma of soft palate with cavernous sinus invasion. World J Surg Oncol. 2010 Mar;8:24. (IF = 1.116)
73. Wu YH, Wu YH, Wang HM, Chen HH, Lin CY, Chen EY, Fan KH, Huang SF, Chen IH, Liao CT, Cheng AJ, Chang JT. Hypothyroidism after radiotherapy for nasopharyngeal cancer patients. Int J Radiat Oncol Biol Phys. 2010 Mar;76:1133-9. (IF = 4.503)
74. Chan SC, Lin CY, Ng SH, Chang JT, Wang HM, Liao CT, Lo CW, Yen TC. 18F-FDG PET for retropharyngeal lymph node metastasis in oropharyngeal and hypopharyngeal cancers: impact on diagnosis and prediction analysis. Nucl Med Commun. 2010 Mar;31:260-5. (IF = 1.367)
75. Huang SF, Liao CT, Chin SC, Chen IH. Transoral approach for plunging ranula-10-Year experience. Laryngoscope. 2010 Jan;120:53-7. (IF = 2.096)
76. Ng SH, Chan SC, Yen TC, Chang JT, Liao CT, Ko SF, Wang HM, Wai YY, Wang JJ, Chen MC. Pretreatment evaluation of distant-site status in patients with nasopharyngeal carcinoma: accuracy of whole-body MRI at 3-Tesla and FDG-PET-CT. Eur Radiol. 2009 Dec;19:2965-76. (IF = 3.594)
77. Chen SC, Tsai MC, Liu CL, Yu WP, Liao CT, Chang JT. Support needs of patients with oral cancer and burden to their family caregivers. Cancer Nurs. 2009 Nov-Dec;32:473-81. (IF = 2.065)
78. Chen SC, Lai YH, Liao CT, Chang JT, Lin CC. Unmet information needs and preferences in newly diagnosed and surgically treated oral cavity cancer patients. Oral Oncol. 2009 Nov;45:946-52. (IF = 2.871)
79. Kang CJ, Chen YJ, Liao CT, Wang HM, Chang JT, Lin CY, Lee LY, Wang TH, Yen TC, Shen CR, Chen IH, Chiu CC, Cheng AJ. Transcriptome profiling and network pathway analysis of genes associated with invasive phenotype in oral cancer. Cancer Lett. 2009 Nov;284:131-40. (IF = 4.864)
80. Chen SC, Liao CT, Lin CC, Chang JT, Lai YH. Distress and care needs in newly diagnosed oral cavity cancer patients receiving surgery. Oral Oncol. 2009 Sep;45:815-20. (IF = 2.871)
81. Huang SF, Chuang WY, Chen IH, Liao CT, Wang HM, Hsieh LL. EGFR protein overexpression and mutation in areca quid-associated oral cavity squamous cell carcinoma in Taiwan. Head Neck. 2009 Aug;31:1068-77. (IF = 2.182)
82. Huang KH, Huang SF, Chen IH, Liao CT, Wang HM, Hsieh LL. Methylation of RASSF1A, RASSF2A, and HIN-1 is associated with poor outcome after radiotherapy, but not surgery, in oral squamous cell carcinoma. Clin Cancer Res. 2009 Jun;15:4174-80. (IF = 7.338)
83. Lin CH, Lin CH, Wu CW, Liao CT. Sternocleidomastoid muscle flap: an option to seal off the esophageal leakage after free jejunal flap transfer - a case report. Chang Gung Med J. 2009 Mar-Apr;32:224-9.
84. Fu CH, Huang SF, Jung SM, Chin SC, Liao CT, Chen IH. Radiology quiz case 2. Extranodal Rosai-Dorfman disease involving the right orbit and nasal cavity. Arch Otolaryngol Head Neck Surg. 2009 Mar;135:317,319. (IF = 1.571)
85. Chung YT, Hsieh LL, Chen IH, Liao CT, Liou SH, Chi CW, Ueng YF, Liu TY. Sulfotransferase 1A1 haplotypes associated with oral squamous cell carcinoma susceptibility in male Taiwanese. Carcinogenesis. 2009 Feb;30:286-94. (IF = 5.402)
86. Huang SF, Chen IH, Liao CT, Wang HM, Liou SH, Hsieh LL. Combined effects of MDM2 SNP 309 and p53 mutation on oral squamous cellcarcinomas associated with areca quid chewing. Oral Oncol. 2009 Jan;45:16-22. (IF = 2.871)
87. Ng SH, Chan SC, Yen TC, Chang JT, Liao CT, Ko SF, Liu FY, Chin SC, Fan KH, Hsu CL. Staging of untreated nasopharyngeal carcinoma with PET/CT: comparison with conventional imaging work–up. Eur J Nucl Med Mol I. 2009 Jan;36:12-22. (IF = 5.036) 
88. Chan SC, Chang JT, Wang HM, Lin CY, Ng SH, Fan KH, Chin SC, Liao CT, Yen TC. Prediction for distant failure in patients with stage M0 nasopharyngeal carcinoma: The role of standardized uptake value. Oral Oncol. 2009 Jan;45:52-8. (IF = 2.871)
89. Ng SH, Chan SC, Liao CT, Chang JT, Ko SF, Wang HM, Chin SC, Lin CY, Huang SF, Yen TC. Distant metastases and synchronous second primary tumors in patients with newly diagnosed oropharyngeal and hypopharyngeal carcinomas: evaluation of (18)F-FDG PET and extended-field multi-detector row CT. Neuroradiology. 2008 Nov;50:969-79. (IF = 2.87)
90. Chiu CC, Lin CY, Lee LY, Chen YJ, Kuo TF, Chang JTC, Liao CT, Wang HM, Yen TC, Shen CR, Liao SK, Cheng AJ. Grp78 regulates multiple malignant phenotypes in head-neck cancer and may serve as a molecular target of therapeutic intervention. Mol Cancer Ther. 2008 Sep;7:2788-97. (IF = 5.225)
91. Chen YJ, Chang JT, Liao CT, Wang HM, Yen TC, Chiu CC, Lu YC, Li HF, Cheng AJ. Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis. Cancer Sci. 2008 Aug;99:1507-14. (IF = 3.846)
92. Chang JT, Chang CH, Juang YY, Hsiao JC, Lin CY, Huang SF, Huang YC, Kuan KH, Liao CT, Wang HM, Chen IH. Internal consistency of the traditional Chinese character version of the Functional Assessment of Cancer Therapy-Head and Neck (FACT-H&N). Chang Gung Med J. 2008 Jul-Aug;31:384-94.
93. Lin CY, Lee LY, Huang SF, Kang CJ, Fan KH, Wang HM, Chen EY, Chen IH, Liao CT, Cheng AJ, Chang JT. Treatment outcome of combined modalities for buccal cancers: Unilateral or bilateral neck radiation? Int J Radiat Oncol Biol Phys. 2008 Apr;70:1373-81. (IF = 4.503)
94. Huang SF, Kang CJ, Lin CY, Fan KH, Yen TC, Wang HM, Chen IH, Liao CT, Cheng AJ, Chang JT. Neck treatment of patients with early stage oral tongue cancer: Comparison between observation, supraomohyoid dissection and extended dissection. Cancer. 2008 Mar;112:1066-75. (IF = 5.131)
95. Lee LA, Cheng AJ, Fang TJ, Huang CG, Liao CT, Chang JT, Li HY. High incidence of malignant transformation of laryngeal papilloma in Taiwan. Laryngoscope. 2008 Jan;118:50-5. (IF = 2.096)
96. Liu FY, Lin CY, Chang JT, Ng SH, Chin SC, Wang HM, Liao CT, Chan SC, Yen TC. 18F-FDG PET can replace conventional work-up in primary M staging of nonkeratinizing nasopharyngeal carcinoma. J Nucl Med. 2007 Oct;48:1614-9. (IF = 7.022)
97. Huang SF, Wu RC, Chang JT, Chan SC, Liao CT, Chen IH, Yeh CN. Intractable bleeding from solitary mandibular metastasis of hepatocellular carcinoma. World J Gastroenterol. 2007 Sep;13:4526-8. (IF = 2.24)
98. Chang JT Chan SH, Lin CY, Lin TY, Wang HM, Liao CT, Wang TH, Lee LY, Cheng AJ. Differentially expressed genes in radioresistant nasopharyngeal cancer cells: gp96 and GDF15. Mol Cancer Ther. 2007 Aug;6:2271-9. (IF = 5.225)
99. Huang SF, Liao CT, Kan CR, Chen IH. Primary mucosa melanoma of the nasal cavity and paranasal sinus: 12 years of experience. J Otolaryngol. 2007 Apr;36:124-9. (IF = 0.551)
100. Fan KH, Lin CY, Kang CJ, Huang SF, Wang HM, Chen EY, Chen IH, Liao CT, Cheng AJ, Chang JT. Combined-modality treatment for advanced oral tongue squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2007 Feb;67:453-61. (IF = 4.503)
101. Chen YJ, Chang JT, Lee L, Wang HM, Liao CT, Chiu CC, Chen PJ, Cheng AJ. DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesis. Oncogene. 2007 Jan;26:467-76. (IF = 7.414)
102. Chang JT, Chen LC, Wei SY, Chen YJ, Wang HM, Liao CT, Chen IH, Cheng AJ Increase diagnostic efficacy by combined use of fingerprint markers in mass spectrometry-plasma peptidomes from nasopharyngeal cancer patients for example. Clin Biochem. 2006 Sep;39:1144-51. (IF = 2.043)
103. Chan SC, Ng SH, Chang JT, Lin CY, Chen YC, Chang YC, Hsu CL Wang HM, Liao CT, Yen TC. Advantages and pitfalls of (18)F-fluro-2D-glucose positron emission tomography in detecting locally residual or recurrent nasopharyngeal carcinoma: comparison with magnetic resonance imaging. Eur J Nucl Med Mol I. 2006 Sep;33:1032-40. (IF = 5.036)
104. Chan SC, Yen TC, Ng SH, Lin CY, Wang HM, Liao CT, Fan KH, Chang JT. Differential roles of 18F-FDG PET in patients with locoregional advanced nasopharyngeal carcinoma after primary curative therapy: Response evaluation and impact on management. J Nucl Med. 2006 Sep;47:1447-54. (IF = 7.022)
105. Yen TC, Lin CY, Wang HM, Huang SF, Liao CT, Kang CJ, Ng SH, Chan SC, Fan KH, Chen IH, Lin WJ, Cheng AJ, Chang JT. (18)F-FDG-PET for evaluation of the response to concurrent chemoradiation therapy with intensity-modulated radiation technique for stage T4 nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2006 Aug;65:1307-14. (IF = 4.503)
106. Huang SF, Chen IH, Liao CT, Chen TM, Lee KF. Sarcomatoid carcinoma of the parotid gland with apparent metastasis of epidermoid elements to cervical lymph nodes. Acta Oto-Laryngol. 2006 Jun;126:667-71. (IF = 1.2)
107. Liu FY, Chang JT, Wang HM, Liao CT, Kang CJ, Ng SK, Chan SC, Yen TC. [18F]fluorodeoxyglucose positron emission tomography is more sensitive than skeletal scintigraphy for detecting bone metastasis in endemic nasopharyngeal carcinoma at initial staging. J Clin Oncol. 2006 Feb;24:599-604. (IF = 18.97)
108. Chan SC, Ko SF, Ng SH, Cheung YC, Chang JT, Liao CT, Wong HM, Lui KW. T-Fastener gastropexy and percutaneous gastrostomy under CT-fluoroscopic guidance in a patient with partial pastrectomy. J Formos Med Assoc. 2006 Feb;105:168-71. (IF = 1.125)
109. Cheng AJ, Chen LC, Chien KY, Chen YJ, Chang JT, Wang HM, Liao CT, Chen IH. Oral cancer plasma tumor marker identified with bead-based affinity-fractionated proteomic technology. Clin Chem. 2005 Dec;51:2236-44. (IF = 6.886)
110. Ng SH, Yen TC, Liao CT, Chang JT, Chan SC, Ko SF, Wang HM, Wong HF. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: A prospective study of 124 patients with histologic correlation. J Nucl Med. 2005 Jul;46:1136-43. (IF = 7.022)
111. Chen SC, Lai YH, Liao CT, Lin CC. Psychometric testing of the impact of event scale-Chinese version (IES-C) in oral cancer patients in Taiwan. Support Care Cancer. 2005 Jul;13:485-92. (IF = 2.058)
112. Chang JT, Chan SC, Yen TC, Liao CT, Lin CY, Lin KJ, Chen IH, Wang HM, Chang YC, Chen TM, Kang CJ, Ng SH. Nasopharyngeal carcinoma staging by (18)F-fluorodeoxyglucose positron emission tomography. Int J Radiat Oncol Biol Phys. 2005 Jun;62:501-7. (IF = 4.503)
113. Chang JT, Wang HM, Chang KW, Chen WH, Wen MC, Hsu YM, Yung BY, Chen IH, Liao CT, Hsieh LL, Cheng AJ. Identification of differentially expressed genes in oral squamous cell carcinoma (OSCC): Overexpression of NPM, CDK1 and NDRG1 and underexpression of CHES1. Int J Cancer. 2005 May;114:942-9. (IF = 4.926)
114. Wang HM, Hsueh CT, Wang CS, Chen IH, Liao CT, Tsai MH, Yeh SP, Chang JT. Phase II trial of cisplatin, tegafur plus uracil and leucovorin as neoadjuvant chemotherapy in patients with squamous cell carcinoma of the oropharynx and hypopharynx. Anti-cancer Drug. 2005 Apr;16:447-53. (IF = 2.376)
115. Hsieh LL, Huang TH, Chen IH, Liao CT, Wang HM, Lai CH, Liou SH, Chang JT, Cheng AJ. P53 polymorphisms associated with mutations in and loos of heterozygosity of the p53 gene in male oral squamous cell carcinomas in Taiwan. Brit J Cancer. 2005 Jan;92:30-5. (IF = 4.831)
116. Wang HM, Liao CT, Chang TC, Chen JS, Liaw CC, Chen IH, Tsang NM. Biweekly paclitaxel, cisplatin, tegafur, and leucovorin as neoadjuvant chemotherapy for unresectable squamous cell carcinoma of the head and neck. Cancer. 2004 Oct;101:1818-23. (IF = 5.131)
117. Ng SH, Joseph CT, Chan SC, Ko SF, Wang HM, Liao CT, Chang YC, Lin WJ, Fu YK, Yen TC. Clinical usefulness of 18F-FDG PET in nasopharyngeal carcinoma patients with questionable MRI findings for recurrence. J Nucl Med. 2004 Oct;45:1669-76. (IF = 7.022)
118. Ng SH, Chang JT, Chan SC, Ko SF, Wang HM, Liao CT, Chang YC, Yen TC. Nodal metastases of nasopharyngeal carcinoma: patterns of disease on MRI and FDG PET. Eur J Nucl Med Mol I. 2004 Aug;31:1073-80. (IF = 5.036)
119. Chang JT, Wong FH, Liao CT, Chen IH, Wang HM, Cheng AJ. Enzyme immunoassay for serum autoantibody to survivin and its findings in head-and-neck cancer patients. Clin Chem. 2004 July;50:1261-4. (IF = 6.886)
120. Chan SC, Ko SF, Ng SH, Cheung YC, Chang JT, Liao CT, Wang HM, Lui KW. Fluoroscopically guided percutaneous gastrostomy with modified gastropexy and a large-bore balloon-retained catheter in patients with head and neck tumors. Acta Radiol. 2004 Apr;45:130-5. (IF = 1.483)
121. Kang CJ, Chang JT, Chen TM, Chen IH, Liao CT. Surgical treatment of oral verrucous carcinoma. Chang Gung Med J. 2003 Nov;26:807-12. 
122. Chen MF, Chang JT, Tsang NM, Liao CT, Chen WC Radiotherapy of early stage glottic cancer: Analysis of factors affecting prognosis. Ann Oto Rhinol Laryn. 2003 Oct;112:904-11. (IF = 1.344)
123. Chen IH, Chang JT, Liao CT, Wang HM, Hsieh LL, Cheng AJ. Prognostic significance of EGFR and Her-2 in oral cavity cancer in betel quid prevalent area. Brit J Cancer. 2003 Aug;89:681-6. (IF = 4.831)
124. Hsieh LL, Chien HT, Chen IH, Liao CT, Wang HM, Jung SM, Wang PF, Chang JT, Chen MC, Cheng AJ. The XRCC1 399Gln Polymorphism and the frequency of p53 mutations in Taiwanese oral squamous cell carcinomas. Cancer Epidem Biomar. 2003 May;12:439-43. (IF = 4.19)
125. Yeow KM, Liao CT, Tsay PK, Chen IH, Cheng MH, Chen HC, Wei FC. Us-guided catheter drainage of postoperative head and neck fluid collections. J Vasc Interv Radiol. 2003 May;14:589-95. (IF = 2.064)
126. Kang CJ, Chen TM, Liao CT, Wang HM. Multiple scalp metastasis from hypopharyngeal carcinoma. J Taiwan Otolaryngol Head Neck Surg. 2003;38:38-41. 
127. Chang JT, Chen IH, Liao CT, Wang HM, Hsu YM, Hung KF, Lin CJ, Hsieh LL, Cheng AJ. A reverse transcription comparative real-time PCR method for quantitative detection of angiogenic growth factors in head and neck cancer patients. Clin Biochem. 2002 Nov;35:591-6. (IF = 2.043)
128. Tseng CP, Cheng AJ, Chang JT, Tseng CH, Wang HM, Liao CT, Chen IH, Tseng KC. Quantitative analysis of multidrug-resistance MDR1 gene expression in head and neck cancer by real-time RT-OCR. Jpn J Cancer Res. 2002 Nov;93:1230-6. 
129. Wang HM, Wang CS, Chen JS, Chen IH, Liao CT, Chang TC. Cisplatin, tegafur, and leucovorin: A moderately effective and minimally toxic outpatient neoadjuvant chemotherapy for locally advanced squamous cell carcinoma of the head and neck. Cancer. 2002 Jun;94:2989-95. (IF = 5.131)
130. Hsieh LL, Wang PF, Chen IH, Liao CT, Wang HM, Chen MC, Chang JT, Cheng AJ. Characteristics of mutations in the p53 gene in oral squamous cell carcinoma associated with betel quid chewing and cigarette smoking in Taiwanese. Carcinogenesis. 2001 Sep;22:1497-503. (IF = 5.402)
131. Chang VC, Chen HC, Hao SP, Liao CT. An adjunct to substernal dissection in esophageal reconstruction. Plast Reconstr Surg. 2001 Jul;108:260-1. (IF = 2.635)
132. Yeow KM, Liao CT, Hao SP. US-guided needle aspiration and catheter drainage as an alternative to open surgical drainage for uniloculated neck abscesses. J Vasc Interv Radiol. 2001 May;12:589-94. (IF = 2.064)
133. Cheng AJ, Chiu DT, See LC, Liao CT, Chen IH, Chang JT. Poor prognosis in nasopharyngeal cancer patient with low glucose-6-phosphate-dehydrogenase activity. Jpn J Cancer Res. 2001 May;92:576-81. 
134. Wang HM, Ng SH, Wang CH, Liao CT, Chen JS, Yang TS, Chen IH. Intra-arterial plus i.v. chemotherapy for advanced bulky squamous cell carcinoma of the buccal mucosa. Anti-cancer Drug. 2001 Apr;12:331-7. (IF = 2.376)
135. Wei FC, Tan BK, Chen IH, Hao SP, Liao CT. Mimicking lip features in free-flap reconstruction of lip defects. Brit J Plast Surg. 2001 Jan;54:8-11. 
136. Chang JT, Liao CT, Jung SM, Wang TC, See LC, Cheng AJ. Telomersae activity is frequently found in metaplastic and malignant human nasopharyngeal tissues. Brit J Cancer. 2000 Jun;82:1946-51. (IF = 4.831)
137. Yeow KM, Hao SP, Liao CT. US-guided percutaneous catheter drainage of parotid abscesses. J Vasc Interv Radiol. 2000 Apr;11:473-6. (IF = 2.064)
138. Chang JT, See LC, Liao CT, Ng SH, Wang CH, Chen IH, Tsang NM, Tseng CK, Tang SG, Hong JH. Locally recurrent nasopharyngeal carcinoma. Radiother Oncol. 2000 Feb;54:135-42. (IF = 4.337)
139. Demirkan F, Chen HC, Wei FC, Chen HH, Jung SG, Hau SP, Liao CT. The versatile anterolateral thigh flap: A musculocutaneous flap in disguise in head and neck reconstruction. Brit J Plast Surg. 2000 Jan;53:30-6. 
140. Yang WB, Lee TJ, Liao CT. Squamous cell carcinoma of the frontal sinus: Case report, J Otolaryngol Society, ROC. 2000;35:212-6. 
141. Chen SM, Liao CT, Yeh PW. Chondrosarcoma of the sphenoid sinus: Case report. J Otolaryngol Society, ROC. 2000;35:428-31. 
142. Chen WC, Liao CT, Tsai HC, Yeh JY, Wang CC, Tang SG, Hong JH. Radiation-induced hearing impairment in patients treated for malignant parotid tumor. Ann Oto Rhinol Laryn. 1999 Dec;108:1159-64. (IF = 1.344)
143. Yeow KM, Hao SP, Liao CT. US-guided percutaneous catheter drainage of a deep retropharyngeal abscess. J Vasc Interv Radiol. 1999 Nov-Dec;10:1365-9. (IF = 2.064)
144. Wang HM, Wang CH, Chen JS, Su CL, Liao CT, Chen IH.  Impact of oral submucous fibrosis on chemotherapy-induced mucositis for head and neck cancer in a geographic area in which betel quid chewing is prevalent. Am J Clin Oncol-Canc. 1999 Oct;22:485-8. (IF = 1.768)
145. Demirkan F, Wei FC, Chen HC, Chen IH, Liao CT. Oromandibular reconstruction using a third free flap in sequence in recurrent carcinoma. Brit J Plast Surg. 1999 Sep;52:429-33.
146. Wei FC, Demirkan F, Chen HC, Chen IH, Liao CT, Hao SP.  Management of secondary soft-tissue deficits following microsurgical head and neck reconstruction by means of another free flap. Plast Reconstr Surg. 1999 Apr;103:1158-66. (IF = 2.635)
147. Sun YC, Liaw CC, Liao CT, Lee KF. Gastric adenocarcinoma with tonsil and submaxillary gland metastases: Case report. Chang Gung Medical J. 1999 Mar;22:143-6. 
148. Demirkan F, Wei FC, Chen HC, Chen IH, Hao SP, Liao CT. Microsurgical reconstruction in recurrent oral cancer: Use of a second free flap in the same patient. Plast Reconstr Surg. 1999 Mar;103:829-38. (IF = 2.635)
149. Hsu CL, Wang HM, Lee CS, Liao CT, Chen TC. Hypopharyngeal carcinoma with clinical peritoneal carcinomatosis: Report of two cases. Am J Clin Oncol. 1998 Aug;21:362-5. 
150. Chang JT, See LC, Liao CT, Chen LH, Leung WM, Chen SW, Chen WC. Early stage nasopharyngeal carcinoma: Radiotherapy dose and time factors in tumor control. Jpn J Clin Oncol. 1998 Mar;28:207-13. 
151. Chang JT, Chen LH, Tang SG, Liao CT, Chen WC, Leung WM, Wang CH, Tsai MH. Acute toxicities and feasibility of altered fractionated radiotherapy in nasopharyngeal carcinoma. Chang Gung Med J. 1997 Jun;20:107-14. 
152. Chen WC, Chen LH, Leung WM, Tang SG, Tsai MH, Liao CT, See LC. Comparison of radiotherapy and surgical results of early stage glottic cancer: A retrospective analysis. J Formos Med Assoc. 1993 Dec;92:1076-83. (IF = 1.125)